Relationships between gastric emptying, postprandial glycemia, and incretin hormones
about
Emerging Evidence for the Importance of Dietary Protein Source on Glucoregulatory Markers and Type 2 Diabetes: Different Effects of Dairy, Meat, Fish, Egg, and Plant Protein FoodsWhey protein: The "whey" forward for treatment of type 2 diabetes?Effect of Cold Storage and Reheating of Parboiled Rice on Postprandial Glycaemic Response, Satiety, Palatability and Chewed Particle Size Distribution.Overview of insulin and non-insulin delivery devices in the treatment of diabetes.Effect of Consuming Oat Bran Mixed in Water before a Meal on Glycemic Responses in Healthy Humans-A Pilot Study.Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects.Impact of glucose tolerance status, sex, and body size on glucose absorption patterns during OGTTs.Relationships of the early insulin secretory response and oral disposition index with gastric emptying in subjects with normal glucose tolerance.Optimizing glycemic control: lixisenatide and basal insulin in combination therapy for the treatment of Type 2 diabetes mellitus.Gastric emptying and glycaemia in health and diabetes mellitus.DPP-4 inhibitors: focus on safety.Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-study.Incretins: player or stayer?Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers.Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review.Novel insights into the effects of diabetes on gastric motility.GLP-1 based therapies: clinical implications for gastroenterologists.Roles of the gut in the metabolic syndrome: an overview.Albiglutide: a unique GLP-1 receptor agonist.Inter-regulation of gastric emptying and incretin hormone secretion: implications for postprandial glycemic control.Individualized, patient-centered use of lixisenatide for the treatment of type 2 diabetes mellitus.Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.Characterizing the dynamic interaction among gastric emptying, glucose absorption, and glycemic control in nondiabetic obese adults.Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review.Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk.Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism.Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial.Multi-parameter comparison of a standardized mixed meal tolerance test in healthy and type 2 diabetic subjects: the PhenFlex challenge.The role of digestive factors in determining glycemic response in a multiethnic Asian population.Carbohydrate-last meal pattern lowers postprandial glucose and insulin excursions in type 2 diabetes.Effect of Oral Pre-Meal Administration of Betaglucans on Glycaemic Control and Variability in Subjects with Type 1 Diabetes.Short-term sleep deprivation with nocturnal light exposure alters time-dependent glucagon-like peptide-1 and insulin secretion in male volunteers.Novel antidiabetic nutrients identified by in vivo screening for gastric secretion and emptying regulation in rats.Diabetes Care to Date: “The Hits Just Keep on Coming!”.Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes.Effect of fibre additions to flatbread flour mixes on glucose kinetics: a randomised controlled trial.Quantitative approaches to energy and glucose homeostasis: machine learning and modelling for precision understanding and prediction.Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
P2860
Q26741760-BD88FA57-A65B-46C3-8C68-E5BC1C434073Q26777875-2A0E345B-5812-4D53-92B5-2B8E72E292E7Q33749395-35FE360A-7624-4F7F-9A02-3CB4D94B84C3Q34688748-173B1350-652F-4A28-989A-87A575E3A57DQ36115748-20092AAE-28FB-4175-9ABF-C0B9B6E86808Q36554216-337915AC-FF44-49FA-8748-FAC2401DABADQ37278088-FF0ADAA8-A365-4F58-9D52-B8537326CAFCQ37670247-2E6B9517-D251-485E-9C03-D52C794BA852Q38154623-99008569-7353-41A6-ACC6-93C300F9E65CQ38271037-8593007A-AA01-48B1-B0FC-3FF563DE1CEFQ38285608-BE454A42-F721-4ECC-8349-4D77936E66AFQ38372787-0BDD4491-B6E1-405B-BE57-82BA8FB27610Q38432296-9B5EC283-FEB7-4506-9173-5F9B12FDB0CCQ38625769-CA42670E-564F-4534-A403-11B5526F22BDQ38634679-A5816469-BAC6-40B9-AC0E-4A49B4D48BE4Q38662831-751E72FE-3ED7-4753-86B6-2FCE4F9A8E77Q38703292-6F3205D6-88C0-42FF-8C0F-51118EB74302Q38780926-37584E1F-9D51-4845-9A3F-80E29829CED9Q38966029-8C8245B7-CEF0-4BFC-813B-D8F486F217E0Q38979407-BD14B3DB-E4AC-438D-890D-D940BA01035FQ38989517-30079436-E16B-4C7F-91F2-87AC0FCDA18DQ39003218-EF2B6B88-351A-41A9-9F6A-049E52419BE0Q39047697-91ED74E8-1AB4-4D4E-AF04-91CAFB5A06CDQ39100650-95B4A924-0D93-4ED8-824C-326369AFD384Q39140474-DD5DAFC6-1620-4A64-9139-B8AA703ECC45Q39325486-D1C7DD62-AD9C-484F-B27E-EC995097C406Q39549540-B9D19218-F50E-4D66-B64F-11C4C1419E6BQ40147836-8F8E437F-F658-4280-B5C2-AA73BDEE7802Q40998901-1824F26F-B4A3-4923-B947-54E56936DE0BQ41558135-DF6BA510-BA6C-40AE-9376-271F3FA07D8BQ41598439-F4819A3B-13AA-43A2-B9B4-9D7900B281B4Q42123265-08C7AF25-2A9E-43A4-B20B-AE6429246C12Q42368244-8F457E14-8233-4A7F-888E-F0DC8AD638C5Q42484592-ABCB842A-5C56-4FC0-82C2-2DE0E3842033Q43917600-19980729-FF33-46F4-8276-57C35A011885Q46388225-117415EB-E5B6-4A91-81FE-94328DE7319EQ47094551-416731C4-AC8E-4C47-911A-6D8D043F6C8EQ47432485-62FC41DA-9804-4D3A-AB88-96AB6676FA23Q47556878-75DD0941-A19F-4578-801D-7B13CA6C7385Q47607423-E7A18241-3C34-4BF7-8004-CD3B896EFD0B
P2860
Relationships between gastric emptying, postprandial glycemia, and incretin hormones
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Relationships between gastric emptying, postprandial glycemia, and incretin hormones
@en
type
label
Relationships between gastric emptying, postprandial glycemia, and incretin hormones
@en
prefLabel
Relationships between gastric emptying, postprandial glycemia, and incretin hormones
@en
P2093
P2860
P356
P1433
P1476
Relationships between gastric emptying, postprandial glycemia, and incretin hormones
@en
P2093
Chinmay S Marathe
Christopher K Rayner
Michael Horowitz
P2860
P304
P356
10.2337/DC12-1609
P407
P577
2013-05-01T00:00:00Z